Education Experience
1992 |
Ph. D. |
Shenyang Pharmaceutical University, CN |
Research Area
The research in the group of Wang involves research and development related to drug advancements and medicinal chemistry, including cardiovascular drugs, anti asthmatic drugs, anti-tumor drugs, anti-virus drugs, anti inflammatory and anti-bacteria drugs, anti-diabetes drugs, benzodiazepine-type hypnotic drugs, non-patented drug development and industrialization. Synthesis of natural products and their structural modification is carried out in this group.
|
Highlighted Publications
Wang, S.; Zhao, H.-M.; Liu, X.-J. 1-(4-Benzyloxyphenyl)-2-bromopropan-1-one. Acta Cryst. Sect. E. 2007, 63, O151. |
Wei, J.; Wang, S.; Gao, S.; Dai, X.; Gao, Q. 3D-pharmacophore Models for Selective A2A and A2B Adenosine receptor Antagonists. J. Chem. Inf. Model. 2007, 47, 613.
|
Wang, S.; Cao, J.; Liu, X. 2-Benzyl-4-chloro-1-(4-nitro Benzyloxy)benzene. Acta Cryst. Sect. E. 2007, 63, 0683.
|
Du, Q. S.; Wang, S.; Chou, K. C. Analogue inhibitors by modifying oseltamivir based on the crystal neuraminidase structure for treating drug-resistant H5N1 virus. Biochem. Biophys. Res. Commun. 2007, 362, 525. |
Wang, S.; Fang, L.; Xiu, J.; Liu, J.; Zhao, K. Design, Synthesis, and Hypnotic Activity Studies of Pyrazolo[1,5-a] pyrimidine Derivatives. Chin. Chem. Lett. 2004, 15, 885. |
ResearcherID Publications
Year |
Title |
Author(s) |
Source |
Volume |
|